Publications (137) José Miguel González-Moro Rodríguez publications

2024

  1. Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 16-22

  2. Occupational Exposures, Chronic Obstructive Pulmonary Disease and Tomographic Findings in the Spanish Population

    Toxics, Vol. 12, Núm. 10

2023

  1. Chronic Respiratory Diseases as a Risk Factor for Herpes Zoster Infection

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 797-804

  2. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811

  3. Dissociation between physical capacity and daily physical activity in COPD patients. A population-based approach

    Respiratory Medicine, Vol. 207

  4. Enhanced fatty acid oxidation through metformin and baicalin as therapy for COVID-19 and associated inflammatory states in lung and kidney

    Redox Biology, Vol. 68

  5. Prevalence of reduced lung diffusing capacity and CT scan findings in smokers without airflow limitation: A population-based study

    BMJ Open Respiratory Research, Vol. 10, Núm. 1

  6. The Clinical Profile of Patients with COPD Is Conditioned by Age

    Journal of Clinical Medicine, Vol. 12, Núm. 24

  7. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 717-724

  8. Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017

    Archivos de Bronconeumologia, Vol. 59, Núm. 3, pp. 142-151

2022

  1. Asma bronquial

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 65, pp. 3829-3837

  2. Decalogue for the selection of oral antibiotics for lower respiratory tract infections

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 16-29

  3. Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study

    Respiratory Research, Vol. 23, Núm. 1

  4. Real-life burden of hospitalisations due to COPD exacerbations in Spain

    ERJ Open Research, Vol. 8, Núm. 3

  5. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients

    International journal of molecular sciences, Vol. 23, Núm. 18

  6. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

    Respiratory Medicine, Vol. 200

  7. Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19

    Science Progress, Vol. 105, Núm. 1

2021

  1. Clinical Management of COPD in a Real-World Setting. A Big Data Analysis

    Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 94-100

  2. Evidencia científica sobre productos de tabaco calentado. Una revisión narrativa

    Revista española de drogodependencias, Núm. 46, pp. 40-57

  3. Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E23-E28